Pfizer Inc. (PFE)
27.82
-0.18
(-0.64%)
USD |
NYSE |
Oct 08, 16:00
27.81
-0.01
(-0.04%)
After-Hours: 19:47
Pfizer Profit Margin (Quarterly) : -1.64% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.64% |
| March 31, 2026 | 18.75% |
| December 31, 2025 | -9.34% |
| September 30, 2025 | 21.32% |
| June 30, 2025 | 19.81% |
| March 31, 2025 | 21.68% |
| December 31, 2024 | 2.31% |
| September 30, 2024 | 25.31% |
| June 30, 2024 | 0.23% |
| March 31, 2024 | 21.02% |
| December 31, 2023 | -22.89% |
| September 30, 2023 | -17.70% |
| June 30, 2023 | 17.99% |
| March 31, 2023 | 30.05% |
| December 31, 2022 | 20.59% |
| September 30, 2022 | 38.19% |
| June 30, 2022 | 35.60% |
| March 31, 2022 | 30.70% |
| December 31, 2021 | 15.01% |
| September 30, 2021 | 34.00% |
| June 30, 2021 | 30.82% |
| March 31, 2021 | 33.65% |
| December 31, 2020 | 5.45% |
| September 30, 2020 | 8.92% |
| June 30, 2020 | 26.40% |
| Date | Value |
|---|---|
| March 31, 2020 | 24.63% |
| December 31, 2019 | -2.58% |
| September 30, 2019 | 60.57% |
| June 30, 2019 | 38.12% |
| March 31, 2019 | 29.65% |
| December 31, 2018 | -2.74% |
| September 30, 2018 | 30.91% |
| June 30, 2018 | 28.81% |
| March 31, 2018 | 27.66% |
| December 31, 2017 | 89.67% |
| September 30, 2017 | 21.70% |
| June 30, 2017 | 23.86% |
| March 31, 2017 | 24.49% |
| December 31, 2016 | 5.60% |
| September 30, 2016 | 10.39% |
| June 30, 2016 | 15.68% |
| March 31, 2016 | 23.44% |
| December 31, 2015 | -1.18% |
| September 30, 2015 | 17.62% |
| June 30, 2015 | 22.23% |
| March 31, 2015 | 21.87% |
| December 31, 2014 | 9.58% |
| September 30, 2014 | 21.65% |
| June 30, 2014 | 22.87% |
| March 31, 2014 | 19.95% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
| Merck & Co., Inc. | -8.06% |
| Bristol Myers Squibb Co. | 25.54% |
| Viatris, Inc. | -3.16% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.92% |
| Return on Assets | 2.12% |
| Return on Invested Capital | 2.86% |
| Gross Profit Margin (Quarterly) | 62.94% |
| Operating Margin (Quarterly) | 22.33% |
| Return on Net Operating Assets | 2.64% |